Trials / Completed
CompletedNCT04060797
Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease
Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease (ED-PAD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Zhongda Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Sympathetic overactivity partly promotes the development of peripheral artery disease which mainly leads to ischemia of the lower limbs. Endovascular arterial denervation (ED) is a minimally invasive technique which could deliver Radiofrequency energy by a multi-electrode catheter to the Lower limb artery to restore Sympathetic activity. The purpose of this study is to evaluate the effects of multi-electrode radiofrequency ablation system on lower limb ischemia with PAD.
Detailed description
Peripheral arterial disease(PAD) show insufficient blood supply of diseased limbs, which causes intermittent claudication of lower limbs, reduced skin temperature, pain, and chronic progressive disease that still produces ulcer or necrosis. Some clinical studies have shown Sympathetic overactivity in the lower arterial ischemic disease. The multi-electrode radiofrequency ablation system can significantly reduce the excitability of sympathetic nerve, restore the normal response of sympathetic nerve, relieve the pain and discomfort of patients, effectively improve the symptoms of lower limb ischemia, and improve the quality of life of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | endovascular denervation | Treating with endovascular denervation (EDN) at the site of the iliac artery distal to the superficial femoral artery proximal before balloon dilation or stent implantation |
| DEVICE | PTA | Treating with balloon dilation or stent implantation which were Percutaneous transluminal angioplasty (PTA) |
Timeline
- Start date
- 2019-08-23
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2019-08-19
- Last updated
- 2024-05-20
- Results posted
- 2024-05-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04060797. Inclusion in this directory is not an endorsement.